|
ZNF616 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.84989999996166E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.04280000026813E-07 |
| Normal-vs-Stage2 |
1.932410E-02 |
| Normal-vs-Stage3 |
2.940200E-02 |
| Normal-vs-Stage4 |
5.015800E-03 |
| Stage1-vs-Stage2 |
4.712400E-01 |
| Stage1-vs-Stage3 |
3.366000E-01 |
| Stage1-vs-Stage4 |
8.418400E-01 |
| Stage2-vs-Stage3 |
9.112200E-01 |
| Stage2-vs-Stage4 |
7.521200E-01 |
| Stage3-vs-Stage4 |
7.110600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.87670000001616E-06 |
| Normal-vs-AfricanAmerican |
5.78399999999757E-05 |
| Normal-vs-Asian |
4.684100E-02 |
| Caucasian-vs-AfricanAmerican |
6.605400E-01 |
| Caucasian-vs-Asian |
4.014400E-01 |
| AfricanAmerican-vs-Asian |
2.748600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.56969999723466E-08 |
| Normal-vs-Female |
2.258400E-01 |
| Male-vs-Female |
1.378860E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.960100E-04 |
| Normal-vs-Extreme_Weight |
2.64120003645729E-09 |
| Normal-vs-Obese |
2.171900E-02 |
| Normal-vs-Extreme_Obese |
2.006300E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.801050E-01 |
| Normal_Weight-vs-Obese |
1.826780E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.582200E-01 |
| Extreme_Weight-vs-Obese |
2.504500E-03 |
| Extreme_Weight-vs-Extreme_Obese |
9.104000E-01 |
| Obese-vs-Extreme_Obese |
1.930950E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.945200E-01 |
| Normal-vs-Age(41-60Yrs) |
5.563300E-04 |
| Normal-vs-Age(61-80Yrs) |
1.38029999985356E-07 |
| Normal-vs-Age(81-100Yrs) |
2.224500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.909000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.847700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.281390E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.063800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.582600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.936000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.04030000064515E-08 |
| Normal-VS-Type2 PRCC |
1.59841999999299E-05 |
| Normal-VS-KIRP CIMP |
6.014800E-01 |
| Normal-VS-Unclassified PRCC |
1.719770E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.729400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.314000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.234190E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.666000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.063600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.287400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62410000004165E-07 |
| Normal-vs-N1 |
4.465000E-01 |
| Normal-vs-N2 |
5.803600E-03 |
| N0-vs-N1 |
2.967700E-02 |
| N0-vs-N2 |
8.754400E-01 |
| N1-vs-N2 |
2.900600E-01 |
|
|
